Antimicrobial resistance: The silent pandemic

post-antimicrobial-age-due-to-antimicrobial-resistance_photo-by-qimono-from-pixabay

Jaspreet Sanghera, Biology and Life Sciences editor When was the last time you had the stomach flu, had your wisdom teeth removed, or had an ear infection? Most likely, you received an antibiotic, a type of antimicrobial drug designed to either prevent or treat bacterial infections. Alexander Fleming’s initial discovery of penicillin in 1928 brought […]

Continue reading


Canadian researchers probe Lyme disease ecology to better understand the dynamics underlying this problematic illness

Brooklyn Bourgeois, new science communicator   A mysterious disease is creeping its way into Saskatchewan, and its diagnosis remains complicated and unstandardized. Lyme disease, a tick-borne bacterial infection, is spreading westwards and northwards into the province of Saskatchewan. The spread is due in part to climate change, which is increasing the range, abundance and activity […]

Continue reading


Premature birth: Understanding why expecting parents give birth unexpectedly early

Nicholas J.C. Bauer, new science communicator   Birth occurring before 37 weeks of pregnancy is a leading cause of newborn death, disability, and developmental delays in humans. With 15 million babies worldwide – and eight per cent of babies in Canada – born prematurely each year, early birth is associated with massive healthcare costs and […]

Continue reading


On the trail of the B.C. bat mortality mystery

Half of the 16 bat species in B.C. are either vulnerable or threatened, and ecologists and farmers alike worry about how the loss of these voracious pest control experts will affect our natural and agricultural systems. Dr. Glenna McGregor, a pathologist at the Canadian Wildlife Health Cooperative, is investigating….

Continue reading


The controversy behind the new FDA-approved drug for Alzheimer’s disease

image-institute-douglas_cc-by-nc-nd

Rana Semaan, Science in Society editor On June 7, 2021, the U.S. Food and Drug Administration (FDA) approved the drug Aduhelm™ (aducanumab-avwa) for the treatment of Alzheimer’s disease under its accelerated approval pathway. I felt overjoyed and excited reading this news. I’d seen the disease up close and lost my grandmother to Alzheimer’s. I immediately […]

Continue reading